Vojtěch Šimka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vojtěch Šimka has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Alberto M. Pereira
2 shared publications- Franz Schaefer
Pediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany
2 shared publications Jana Jedličková
2 shared publicationsMari Murel
2 shared publicationsNela Navrátilová
2 shared publicationsOndřEj Hynek
2 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 83
Exploring national support mechanisms for European reference network centres
- 7 August 2026
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 83
Open AccessExploring national support mechanisms for European reference network centres
- Open Access
- 5 June 2026
- Published by Elsevier in SSRN Electronic Journal
Exploring National Support Mechanisms for European Reference Network Centres: An Overview from JARDIN Work Package 9
Integrating European Reference Networks (ERNs) into national health systems is crucial for rare disease care but remains challenging due to inconsistent support structures across countries. This study used a 2024–2025 multi-stakeholder survey of ERN clinical centre leads, hospital administrators, and national health authorities (JARDIN Joint Action, Work Package 9) to evaluate national support for ERN centres across six domains: staffing, education, formal recognition, funding, quality assurance, and strategic planning. Survey results revealed inconsistent national legal frameworks for recognizing ERN centres, major staffing deficits, and limited dedicated funding for ERN activities. Strategic planning for rare disease networks was often lacking, and institutional support for ERN-related quality assurance and continuing education remained low. Notably, ERN membership was associated with increased educational activities for health professionals, but these initiatives often lacked sustainability due to insufficient protected time and resources. Overall, the findings highlight that embedding ERNs into national health systems will require formal recognition of ERN centres in policy, consistent funding, stronger institutional backing, and structured support mechanisms to address workforce and quality gaps, ensuring long-term sustainability of this collaborative rare disease network.
- 5 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessExploring National Support Mechanisms for European Reference Network Centres: An Overview from JARDIN Work Package 9
Integrating European Reference Networks (ERNs) into national health systems is crucial for rare disease care but remains challenging due to inconsistent support structures across countries. This study used a 2024–2025 multi-stakeholder survey of ERN clinical centre leads, hospital administrators, and national health authorities (JARDIN Joint Action, Work Package 9) to evaluate national support for ERN centres across six domains: staffing, education, formal recognition, funding, quality assurance, and strategic planning. Survey results revealed inconsistent national legal frameworks for recognizing ERN centres, major staffing deficits, and limited dedicated funding for ERN activities. Strategic planning for rare disease networks was often lacking, and institutional support for ERN-related quality assurance and continuing education remained low. Notably, ERN membership was associated with increased educational activities for health professionals, but these initiatives often lacked sustainability due to insufficient protected time and resources. Overall, the findings highlight that embedding ERNs into national health systems will require formal recognition of ERN centres in policy, consistent funding, stronger institutional backing, and structured support mechanisms to address workforce and quality gaps, ensuring long-term sustainability of this collaborative rare disease network.
- Open Access
- 1 December 2025
- Published by Springer Nature in Research Square
Rare Disease Data Management across Europe: Insights from the JARDIN Survey on Data Sharing and Interoperability
Introduction: Integration of Rare Disease (RD) data from local Healthcare Providers (HCPs) into national RD databases and European Reference Networks (ERNs) is essential for the improvement of care for RD patients, e.g. for unsolved case and development of novel therapies. However, connectivity between ERNs and national or regional RD databases remains limited, despite ongoing efforts to reduce barriers. The continued lack of standardized approaches hampers effective cross-border medical data use. Method: A European-wide survey, conducted as part of the Joint Action on Integration of ERNs into National Healthcare Systems (JARDIN), aimed to assess current practices and to identify barriers, and solutions for sharing of RD data across European Union (EU) Member States and associated countries. The survey targeted clinicians and IT experts at the hospital levels, receiving 457 (52.3%) and 100 responses (58.5%), respectively. Data were analysed using frequency distributions and total counts. Results: The analysis reveals significant fragmentation in digital infrastructure, data standards, and consent practices. While a few countries collect patient information fully digitally, with implementation of national RD registries and ORPHAcode policies, the majority still relies on paper-based documentation. Data sharing with ERNs remains largely a manual effort, with limited automation and low implementation of FAIR (Findable, Accessible, Interoperable, Reusable) principles as enabler of this automation. Lastly, consent management is inconsistent, mostly paper-based, and poorly integrated into hospital data collection systems. Conclusions: The survey underscores the importance of fostering dialogues around common barriers, limitations, and ongoing projects that support the adoption of existing solutions and best practices. Within JARDIN, a broad range of tools, standards and infrastructures developed through previous and ongoing European initiatives were identified. These address various challenges from semantic standards and FAIR data principles to consent frameworks, data-sharing infrastructures, and governance models. The survey emphasizes the need for policymakers, hospital IT coordinators and RD researchers to start with the widespread, practical implementation of these solutions.
- 1 December 2025
- Published by Springer Nature in Research Square
Open AccessRare Disease Data Management across Europe: Insights from the JARDIN Survey on Data Sharing and Interoperability
Introduction: Integration of Rare Disease (RD) data from local Healthcare Providers (HCPs) into national RD databases and European Reference Networks (ERNs) is essential for the improvement of care for RD patients, e.g. for unsolved case and development of novel therapies. However, connectivity between ERNs and national or regional RD databases remains limited, despite ongoing efforts to reduce barriers. The continued lack of standardized approaches hampers effective cross-border medical data use. Method: A European-wide survey, conducted as part of the Joint Action on Integration of ERNs into National Healthcare Systems (JARDIN), aimed to assess current practices and to identify barriers, and solutions for sharing of RD data across European Union (EU) Member States and associated countries. The survey targeted clinicians and IT experts at the hospital levels, receiving 457 (52.3%) and 100 responses (58.5%), respectively. Data were analysed using frequency distributions and total counts. Results: The analysis reveals significant fragmentation in digital infrastructure, data standards, and consent practices. While a few countries collect patient information fully digitally, with implementation of national RD registries and ORPHAcode policies, the majority still relies on paper-based documentation. Data sharing with ERNs remains largely a manual effort, with limited automation and low implementation of FAIR (Findable, Accessible, Interoperable, Reusable) principles as enabler of this automation. Lastly, consent management is inconsistent, mostly paper-based, and poorly integrated into hospital data collection systems. Conclusions: The survey underscores the importance of fostering dialogues around common barriers, limitations, and ongoing projects that support the adoption of existing solutions and best practices. Within JARDIN, a broad range of tools, standards and infrastructures developed through previous and ongoing European initiatives were identified. These address various challenges from semantic standards and FAIR data principles to consent frameworks, data-sharing infrastructures, and governance models. The survey emphasizes the need for policymakers, hospital IT coordinators and RD researchers to start with the widespread, practical implementation of these solutions.